Title:
SALT FORM AND CRYSTAL FORM OF 1,2,4-TRIAZINE-3,5-DIONE COMPOUND, AND PREPARATION METHOD THEREFOR
Document Type and Number:
WIPO Patent Application WO/2022/194073
Kind Code:
A1
Abstract:
Disclosed in the present invention are a salt form and a crystal form of a 1,2,4-triazine-3,5-dione (Formula I) compound, a preparation method therefor, and the use thereof in the treatment and/or the preparation of a drug. The use is to treat diseases related to thyroid hormone receptors.
Inventors:
LV HEJUN (CN)
WANG PENG (CN)
YE WENWU (CN)
JI HAIXIA (CN)
LIU JUNFENG (CN)
WANG PENG (CN)
YE WENWU (CN)
JI HAIXIA (CN)
LIU JUNFENG (CN)
Application Number:
PCT/CN2022/080571
Publication Date:
September 22, 2022
Filing Date:
March 14, 2022
Export Citation:
Assignee:
KPC PHARMACEUTICALS INC (CN)
SHANGHAI KUNHENG PHARMA TECH CO LTD (CN)
SHANGHAI KUNHENG PHARMA TECH CO LTD (CN)
International Classes:
C07D237/14; A61K31/501; A61K31/53; A61P5/16; C07D237/16; C07D237/18; C07D403/10; C07D403/12
Domestic Patent References:
| WO2021104288A1 | 2021-06-03 | |||
| WO2020239076A1 | 2020-12-03 | |||
| WO2007009913A1 | 2007-01-25 | |||
| WO2020227549A1 | 2020-11-12 |
Foreign References:
| CN111801324A | 2020-10-20 | |||
| CN105008335A | 2015-10-28 |
Attorney, Agent or Firm:
UNITALEN ATTORNEYS AT LAW (CN)
Download PDF: